BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 31842997)

  • 21. MicroRNA-223 dose levels fine tune proliferation and differentiation in human cord blood progenitors and acute myeloid leukemia.
    Gentner B; Pochert N; Rouhi A; Boccalatte F; Plati T; Berg T; Sun SM; Mah SM; Mirkovic-Hösle M; Ruschmann J; Muranyi A; Leierseder S; Argiropoulos B; Starczynowski DT; Karsan A; Heuser M; Hogge D; Camargo FD; Engelhardt S; Döhner H; Buske C; Jongen-Lavrencic M; Naldini L; Humphries RK; Kuchenbauer F
    Exp Hematol; 2015 Oct; 43(10):858-868.e7. PubMed ID: 26163797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Screening and expression of CD34(+) cell-specific microRNA in acute myelogenous leukemia].
    Wang GP; Zhang SQ; Zhu P; Peng MY; Tan SQ; Yin H; Xu YJ; Chen Y; Chen FP
    Zhonghua Xue Ye Xue Za Zhi; 2012 Jul; 33(7):541-5. PubMed ID: 22967414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. microRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia.
    Han YC; Park CY; Bhagat G; Zhang J; Wang Y; Fan JB; Liu M; Zou Y; Weissman IL; Gu H
    J Exp Med; 2010 Mar; 207(3):475-89. PubMed ID: 20212066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-210 transferred by lung cancer cell-derived exosomes may act as proangiogenic factor in cancer-associated fibroblasts by modulating JAK2/STAT3 pathway.
    Fan J; Xu G; Chang Z; Zhu L; Yao J
    Clin Sci (Lond); 2020 Apr; 134(7):807-825. PubMed ID: 32219336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The PU.1-Modulated MicroRNA-22 Is a Regulator of Monocyte/Macrophage Differentiation and Acute Myeloid Leukemia.
    Shen C; Chen MT; Zhang XH; Yin XL; Ning HM; Su R; Lin HS; Song L; Wang F; Ma YN; Zhao HL; Yu J; Zhang JW
    PLoS Genet; 2016 Sep; 12(9):e1006259. PubMed ID: 27617961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNAs expressed in hematopoietic stem/progenitor cells are deregulated in acute myeloid leukemias.
    Testa U; Pelosi E
    Leuk Lymphoma; 2015 May; 56(5):1466-74. PubMed ID: 25242094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute myeloid leukemia-induced functional inhibition of healthy CD34+ hematopoietic stem and progenitor cells.
    Jäger P; Geyh S; Twarock S; Cadeddu RP; Rabes P; Koch A; Maus U; Hesper T; Zilkens C; Rautenberg C; Bormann F; Köhrer K; Petzsch P; Wieczorek D; Betz B; Surowy H; Hildebrandt B; Germing U; Kobbe G; Haas R; Schroeder T
    Stem Cells; 2021 Sep; 39(9):1270-1284. PubMed ID: 34013984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Knockdown of miR-128a induces Lin28a expression and reverts myeloid differentiation blockage in acute myeloid leukemia.
    De Luca L; Trino S; Laurenzana I; Tagliaferri D; Falco G; Grieco V; Bianchino G; Nozza F; Campia V; D'Alessio F; La Rocca F; Caivano A; Villani O; Cilloni D; Musto P; Del Vecchio L
    Cell Death Dis; 2017 Jun; 8(6):e2849. PubMed ID: 28569789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of O-GlcNAcase Inhibits Hematopoietic and Leukemic Stem Cell Self-Renewal and Drives Dendritic Cell Differentiation via STAT3/5 Signaling.
    Luanpitpong S; Rodboon N; Samart P; Janan M; Klaihmon P; Lorthongpanich C; U-Pratya Y; Issaragrisil S
    Stem Cells; 2022 Dec; 40(12):1078-1093. PubMed ID: 36124999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exosomes derived from human bone marrow mesenchymal stem cells transfer miR-222-3p to suppress acute myeloid leukemia cell proliferation by targeting IRF2/INPP4B.
    Zhang F; Lu Y; Wang M; Zhu J; Li J; Zhang P; Yuan Y; Zhu F
    Mol Cell Probes; 2020 Jun; 51():101513. PubMed ID: 31968218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of CD90, CD96, CD117, and CD123 on different hematopoietic cell populations from pediatric patients with acute myeloid leukemia.
    Chávez-González A; Dorantes-Acosta E; Moreno-Lorenzana D; Alvarado-Moreno A; Arriaga-Pizano L; Mayani H
    Arch Med Res; 2014 May; 45(4):343-50. PubMed ID: 24751333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Micro-RNA Profiling of Exosomes from Marrow-Derived Mesenchymal Stromal Cells in Patients with Acute Myeloid Leukemia: Implications in Leukemogenesis.
    Barrera-Ramirez J; Lavoie JR; Maganti HB; Stanford WL; Ito C; Sabloff M; Brand M; Rosu-Myles M; Le Y; Allan DS
    Stem Cell Rev Rep; 2017 Dec; 13(6):817-825. PubMed ID: 28918518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exosomes from bone marrow mesenchymal stem cells decrease chemosensitivity of acute myeloid leukemia cells via delivering miR-10a.
    Wu J; Zhang Y; Li X; Ren J; Chen L; Chen J; Cao Y
    Biochem Biophys Res Commun; 2022 Sep; 622():149-156. PubMed ID: 35863089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-143 targets ERK5 in granulopoiesis and predicts outcome of patients with acute myeloid leukemia.
    Hartmann JU; Bräuer-Hartmann D; Kardosova M; Wurm AA; Wilke F; Schödel C; Gerloff D; Katzerke C; Krakowsky R; Namasu CY; Bill M; Schwind S; Müller-Tidow C; Niederwieser D; Alberich-Jorda M; Behre G
    Cell Death Dis; 2018 Jul; 9(8):814. PubMed ID: 30050105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mesenchymal niche remodeling impairs hematopoiesis via stanniocalcin 1 in acute myeloid leukemia.
    Waclawiczek A; Hamilton A; Rouault-Pierre K; Abarrategi A; Albornoz MG; Miraki-Moud F; Bah N; Gribben J; Fitzgibbon J; Taussig D; Bonnet D
    J Clin Invest; 2020 Jun; 130(6):3038-3050. PubMed ID: 32364536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CITED2-mediated human hematopoietic stem cell maintenance is critical for acute myeloid leukemia.
    Korthuis PM; Berger G; Bakker B; Rozenveld-Geugien M; Jaques J; de Haan G; Schuringa JJ; Vellenga E; Schepers H
    Leukemia; 2015 Mar; 29(3):625-35. PubMed ID: 25184385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA hypermethylation-induced miR-182 silence targets BCL2 and HOXA9 to facilitate the self-renewal of leukemia stem cell, accelerate acute myeloid leukemia progression, and determine the sensitivity of BCL2 inhibitor venetoclax.
    Ye S; Xiong F; He X; Yuan Y; Li D; Ye D; Shi L; Lin Z; Zhao M; Feng S; Zhou B; Weng H; Hong L; Ye H; Gao S
    Theranostics; 2023; 13(1):77-94. PubMed ID: 36593968
    [No Abstract]   [Full Text] [Related]  

  • 38. Expression of granulocyte colony-stimulating factor- and granulocyte-macrophage colony-stimulating factor-associated signal transduction proteins of the JAK/STAT pathway in normal granulopoiesis and in blast cells of acute myelogenous leukemia.
    Biethahn S; Alves F; Wilde S; Hiddemann W; Spiekermann K
    Exp Hematol; 1999 May; 27(5):885-94. PubMed ID: 10340405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extracellular vesicle miR-7977 is involved in hematopoietic dysfunction of mesenchymal stromal cells via poly(rC) binding protein 1 reduction in myeloid neoplasms.
    Horiguchi H; Kobune M; Kikuchi S; Yoshida M; Murata M; Murase K; Iyama S; Takada K; Sato T; Ono K; Hashimoto A; Tatekoshi A; Kamihara Y; Kawano Y; Miyanishi K; Sawada N; Kato J
    Haematologica; 2016 Apr; 101(4):437-47. PubMed ID: 26802051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of Acute Myeloid Leukemia (AML)-Derived exosomes in tumor progression and survival.
    Amin AH; Sharifi LMA; Kakhharov AJ; Opulencia MJC; Alsaikhan F; Bokov DO; Majdi HS; Jawad MA; Hammid AT; Shalaby MN; Mustafa YF; Siahmansouri H
    Biomed Pharmacother; 2022 Jun; 150():113009. PubMed ID: 35486974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.